Cancer survival in five continents: a worldwide population-based study (CONCORD)

The Lancet Oncology

Volumn 9, Issue 8, 2008, Pages 730-756

  Coleman, Michel P ^a   Quaresma, Manuela ^a   Berrino, Franco ^b   Lutz, Jean Michel ^c   De Angelis, Roberta ^d   Capocaccia, Riccardo ^d   Baili, Paolo ^b   Rachet, Bernard ^a   Gatta, Gemma ^b   Hakulinen, Timo ^e   Micheli, Andrea ^b   Sant, Milena ^b   Weir, Hannah K ^f   Elwood, J Mark ^g   Tsukuma, Hideaki ^h   Koifman, Sergio ⁱ   e Silva, Gulnar Azevedo ^j   Francisci, Silvia ^d   Santaquilani, Mariano ^d   Verdecchia, Arduino ^d   Storm, Hans H ^k   Young, John L ^l   more..

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c GENEVA CANCER REGISTRY   (Switzerland)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e FINNISH CANCER REGISTRY   (Finland)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g BRITISH COLUMBIA CANCER AGENCY   (Canada)

^h OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

ⁱ INSTITUTO OSWALDO CRUZ   (Brazil)

^j FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^k DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^l Department of Epidemiology   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ALGERIA; ANALYTIC METHOD; ARTICLE; AUSTRALIA; BRAZIL; BREAST CANCER; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; COLORECTAL CANCER; ETHNICITY; EUROPE; FEMALE; GENDER; HUMAN; JAPAN; LIFE TABLE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; RACE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROBABILITY; REGISTRIES; RISK FACTORS; SEER PROGRAM; SEX DISTRIBUTION; SURVIVAL ANALYSIS; WORLD HEALTH;

EID: 48049120399     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70179-7     Document Type: Article

References (130)

1. Hakulinen T. A comparison of nationwide cancer survival statistics in Finland and Norway. World Health Stat Q 36 (1983) 35-46
2. Engeland A., Haldorsen T., Dickman P., et al. Relative survival of cancer patients: a comparison between Denmark and other Nordic countries. Acta Oncol 37 (1998) 49-59
3. Gorey K., Holowaty E., Laukkanen E., Fehringer G., and Richter N. An international comparison of cancer survival: advantage of Toronto's poor over the near-poor of Detroit. Rev Canad Santé Publ 89 (1998) 102-104
4. In: Sankaranarayanan R., Black R., and Parkin D. (Eds). Cancer survival in developing countries (1998), IARC Scientific Publications No 145, Lyon
5. Verdecchia A., Mariotto A., Gatta G., Bustamente-Teixeira M., and Ajiki W. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 39 (2003) 1603-1609
6. Coleman M., Babb P., Damiecki P., et al. Cancer survival trends in England and Wales 1971-1995: deprivation and NHS Region. (Studies on Medical and Population Subjects No 61) (1999), The Stationery Office, London 55-106
7. Sant M., and EUROCARE Working Group. Overview of EUROCARE-2 results on survival of cancer patients diagnosed 1985-89. In: Berrino F., Capocaccia R., Estève J., et al. (Eds). Survival of cancer patients in Europe: the EUROCARE-2 study (1999), IARC Scientific Publications No 151, Lyon 525-541
8. SEER*Stat-cancer incidence public use database 1973-95, Version 1.1 (1998), National Cancer Institute, Bethesda, MD
9. Gatta G., Capocaccia R., Coleman M., et al. Toward a comparison of survival in American and European cancer patients. Cancer 89 (2000) 893-900
10. Sant M., Allemani C., Berrino F., et al. Breast carcinoma survival in Europe and the USA: a population-based study. Cancer 100 (2004) 715-722
11. Gatta G., Capocaccia R., Coleman M., Gloeckler Ries L., and Berrino F. Childhood cancer survival in Europe and the United States. Cancer 95 (2002) 1767-1772
12. Gatta G., Ciccolallo L., Capocaccia R., et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 39 (2003) 2214-2222
13. McDavid K., Schymura M., Armstrong L., et al. Rationale and design of the National Program of Cancer Registries' Breast, Colon, and Prostate Cancer Patterns of Care Study. Cancer Causes Control 15 (2004) 1057-1066
14. Allemani C., Sant M., De Angelis R., Marcos-Gragera R., Coebergh J., and EUROCARE Working Group. Hodgkin disease survival in Europe and the US: prognostic significance of morphologic groups. Cancer 107 (2006) 352-360
15. Capocaccia R., Sant M., Berrino F., et al. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th Century. Am J Gastroenterol 102 (2007) 1661-1670
16. Sant M., Allemani C., De Angelis R., et al. Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States. Eur J Cancer 44 (2008) 579-587
17. In: Cutler S. (Ed). International symposium on end results of cancer therapy. NCI Monograph 15 (1964), National Cancer Institute, Bethesda MD
18. Berkson J., and Gage R. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clinic 25 (1950) 270-286
19. Cutler S., and Ederer F. Maximum utilisation of the life table method in analyzing survival. J Chron Dis 8 (1958) 699-712
20. Ederer F., Axtell L., and Cutler S. The relative survival: a statistical methodology. Natl Cancer Inst Monogr 6 (1961) 101-121
21. Farrow D., Samet J., and Hunt W. Regional variation in survival following the diagnosis of cancer. J Clin Epidemiol 49 (1996) 843-847
22. Coleman M., Gatta G., Verdecchia A., et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14 suppl 5 (2003) 128-149
23. Coleman M., Babb P., Damiecki P., et al. Cancer survival trends in England and Wales 1971-1995: deprivation and NHS Region. (Studies on Medical and Population Subjects No. 61) (1999), The Stationery Office, London 1-695
24. EUROCARE Working Group. Publications from the EUROCARE study. EUROCARE Working Group. http://www.eurocare.it (accessed June 15, 2007).
25. In: Berrino F., Sant M., Verdecchia A., Capocaccia R., Hakulinen T., and Estève J. (Eds). Survival of cancer patients in Europe: the EUROCARE study (1995), IARC Scientific Publications No 132, Lyon
26. In: Berrino F., Capocaccia R., Estève J., et al. (Eds). Survival of cancer patients in Europe: the EUROCARE-2 study (1999), IARC Scientific Publications No 151, Lyon
27. Sant M., Aareleid T., Berrino F., et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 14 suppl 5 (2003) 61-118
28. In: Berrino F., Capocaccia R., Coleman M., et al. (Eds). EUROCARE-3: the survival of cancer patients diagnosed in Europe during 1990-94. Ann Oncol 14 suppl 5 (2003) 1-155
29. Berrino F., De Angelis R., Sant M., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8 (2007) 773-783
30. Verdecchia A., Francisci S., Brenner H., et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8 (2007) 784-796
31. In: Parkin D., Whelan S., Ferlay J., Raymond L., and Young J. (Eds). Cancer incidence in five continents volume VII (1997), IARC Scientific Publications No 143, Lyon
32. In: Chen V., Wu X., and Andrews P. (Eds). Cancer in North America 1991-1995, Vol 1. Incidence (1999), North American Association of Central Cancer Registries, Sacramento, CA
33. Coleman M., Berrino F., Capocaccia R., et al. The CONCORD protocol (rev. 2001). CONCORD Steering Committee. http://www.lshtm.ac.uk/ncdeu/concordinvestigatorsmtg/CONCORD%20Protocol. pdf (accessed July 3, 2008).
34. CONCORD Working Group. CONCORD study. Cancer Research UK Cancer Survival Group. http://www.lshtm.ac.uk/ncdeu/cancersurvival/concord/phase1/index.htm (accessed July 3, 2008).
35. United Nations. Countries and states by UN region. United Nations. http://unstats.un.org/unsd/methods/m49/m49regin.htm (accessed July 3, 2008).
36. US Cancer Statistics Working Group. United States Cancer Statistics: 2004 Incidence and Mortality (2007), US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta GA
37. National Cancer Institute. Surveillance research. National Cancer Institute. http://surveillance.cancer.gov/statistics/types/survival.html (accessed July 3, 2008).
38. National Cancer Institute. Incidence-SEER 9 public-use data, 2002: cases diagnosed 1973-2000. National Institutes of Health. www.seer.cancer.gov/seerstat (accessed July 3, 2008).
39. World Health Organization. International Classification of Diseases, 1975, 9th revision (1977), WHO, Geneva
40. World Health Organization. International Classification of Diseases for Oncology (ICD-O) (1976), World Health Organization, Geneva
41. In: Percy C., Van Holten V., and Muir C. (Eds). International Classification of Diseases for Oncology (ICD-O). second edition (1990), World Health Organization, Geneva
42. Parkin D., Chen V., Ferlay J., Galceran J., Storm H., and Whelan S. Comparability and quality control in cancer registration. IARC Technical Report No 19 (1994), IARC, Lyon
43. Capocaccia R., Gatta G., Roazzi P., et al. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 14 suppl 5 (2003) 14-27
44. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 38 (1982) 933-942
45. National Cancer Institute SEER*Stat software, Version 6.3.5 (2007), National Cancer Institute, Bethesda, MD
46. Baili P, Micheli A, De Angelis R, et al. CONCORD Working Group, CONCORD study: comparable life tables for world-wide analysis of relative survival for cancer. Tumori (in press).
47. Brawley O., and Freeman H. Race and outcomes: is this the end of the beginning for minority health research?. J Natl Cancer Inst 91 (1999) 1908-1909
48. Richardson J., Langholz B., Bernstein L., Burciaga C., Danley K., and Ross R. Stage and delay in breast cancer diagnosis by race, socio-economic status, age and year. Br J Cancer 65 (1992) 922-926
49. Ansell D., Whitman S., Lipton R., and Cooper R. Race, income, and survival from breast cancer at two public hospitals. Cancer 72 (1993) 2974-2978
50. Greenwald H., Polissar N., and Dayal H. Race, socioeconomic status and survival in three female cancers. Ethn Health 1 (1996) 65-75
51. Dignam J. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin 50 (2000) 50-64
52. Dignam J., Colangelo L., Tian W., et al. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst 91 (1999) 1933-1940
53. Bach P., Schrag D., Brawley O., Galaznik A., Yakren S., and Begg C. Survival of blacks and whites after a cancer diagnosis. J Amer Med Assoc 287 (2002) 2106-2113
54. Farooq S., and Coleman M. Breast cancer survival in South Asian women in England and Wales. J Epidemiol Community Health 59 (2005) 402-406
55. dos Santos Silva I., Mangtani P., De Stavola B., Bell C., Quinn M., and Mayer D. Survival from breast cancer among South Asian and non-South Asian women resident in South East England. Br J Cancer 89 (2003) 508-512
56. Hakulinen T. On long-term relative survival rates. J Chron Dis 30 (1977) 431-443
57. Estève J., Benhamou E., Croasdale M., and Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat Med 9 (1990) 529-538
58. Smith P. Comparison between registries: age-standardized rates. In: Parkin D., Muir C., Whelan S., Gao Y.-T., Ferlay J., and Powell J. (Eds). Cancer Incidence in Five Continents volume V (1992), IARC Scientific Publications No 120, Lyon 865-870
59. Black R., and Bashir S. World standard cancer patient populations: a resource for comparative analysis of survival data. In: Sankaranarayanan R., Black R., and Parkin D. (Eds). Cancer survival in developing countries (1998), IARC Scientific Publications No 145, Lyon 9-11
60. Corazziari I., Quinn M., and Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40 (2004) 2307-2316
61. Greenwood M. The natural duration of cancer. (Report on Public Health and Medical Subjects No 33) (1926), HMSO, London
62. Spiegelhalter D. Funnel plots for comparing institutional performance. Stat Med 24 (2005) 1185-1202
63. In: Parkin D., Whelan S., Ferlay J., Teppo L., and Thomas D. (Eds). Cancer incidence in five continents volume VIII (2002), IARC Scientific Publications No 155, Lyon
64. In: Doll R., Payne P., and Waterhouse J. (Eds). Cancer incidence in five continents: a technical report (1966), UICC, Geneva
65. Coleman M., Estève J., Damiecki P., Arslan A., and Renard H. Trends in cancer incidence and mortalit (1993), IARC Scientific Publications No 121, Lyon 1-806
66. Pisani P., Parkin D., Bray F., and Ferlay J. Estimates of the worldwide mortality from 25 major cancers in 1990. Int J Cancer 83 (1999) 18-29
67. Bray F., McCarron P., and Parkin D. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6 (2004) 229-239
68. Bailar J., and Gornik H. Cancer undefeated. N Engl J Med 336 (1997) 1569-1574
69. Bailar J., and Smith E. Progress against cancer?. N Engl J Med 314 (1986) 1226-1232
70. Doll R. Are we winning the fight against cancer?. Eur J Cancer 26 (1990) 500-508
71. Doll R. Are we winning the war against cancer? A review in memory of Keith Durrant. Clin Oncol 4 (1992) 257-266
72. Doll R. Progress against cancer: are we winning the war?. Acta Oncol 28 (1989) 611-621
73. Percy C., and Dolman A. Comparison of the coding of death certificates related to cancer in seven countries. Public Health Rep 93 (1978) 335-350
74. Percy C., Garfinkel L., Krueger D., and Dolman A. Apparent changes in cancer mortality, 1968: a study of the effects of the introduction of the eighth revision International Classification of Diseases. Public Health Rep 89 (1974) 418-428
75. Laurenti R., Coleman M., and Aylin P. Accuracy of statements of the cause of death on death certificates and the international comparability of mortality statistics. In: Coleman M., and Aylin P. (Eds). Death certification and mortality statistics: an international perspective (2000), Office for National Statistics, London
76. Extramural Committee to Assess Measures of Progress Against Cancer. Measurement of progress against cancer. J Natl Cancer Inst 82 (1990) 825-835
77. Richards M. EUROCARE-4 studies bring new data on cancer survival. Lancet Oncol 8 (2007) 752-753
78. Coleman M., Babb P., Stockton D., Møller H., and Forman D. Trends in breast cancer incidence, survival and mortality. Lancet 356 (2000) 590-591
79. Tsukuma H., Ajiki W., Ioka A., Oshima A., and Research Group of Population-based Cancer Registries of Japan. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol 36 (2006) 602-607
80. Fernandez Garrote L., Boschmonar M.G., Alvarez Y.G., Cicilli M.L., Garcia A.M., and Rodriguez R.C. Cancer survival in Cuba. In: Sankaranarayanan R., Black R., and Parkin D. (Eds). Cancer survival in developing countries (1998), IARC Scientific Publications No 145, Lyon 51-59
81. Brenner H. Limitations of the death certificate only index as a measure of incompleteness of cancer registration. Br J Cancer 72 (1995) 506-510
82. Berrino F., Estève J., and Coleman M. Basic issues in the estimation and comparison of cancer patient survival. In: Berrino F., Sant M., Verdecchia A., Capocaccia R., Hakulinen T., and Estève J. (Eds). Survival of cancer patients in Europe: the EUROCARE study (1995), IARC Scientific Publications No 132, Lyon 1-14
83. Robinson D., Sankila R., Hakulinen T., and Møller H. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer 43 (2007) 909-913
84. Berrino F. The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies. Ann Oncol 14 suppl 5 (2003) 9-13
85. Schlemper R., Itabashi M., Kato Y., et al. Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer 82 (2000) 60-69
86. Jass J., and Sobin L. Histological typing of intestinal tumours. WHO international histological classification of tumours. 2nd edn. (1989), Springer-Verlag, Berlin
87. Cooper H., Deppisch L., Kahn E., et al. Pathology of the malignant colorectal polyp. Hum Pathol 29 (1998) 15-26
88. van der Esch E., Muir C., Nectoux J., et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 47 (1991) 483-490
89. Gondos A., Chokunonga E., Brenner H., et al. Cancer survival in a southern African urban population. Int J Cancer 112 (2004) 860-864
90. Boschmonar M.G., Garcia A.M., Soto T., Roger M., and Garrote L.F. Childhood cancer survival in Cuba. Eur J Epidemiol 16 (2000) 763-767
91. Yu X., O'Connell D., and Forman D. Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites. Br J Cancer 91 (2004) 1663-1665
92. Woods L. International differences in breast cancer survival and 'cure' by social deprivation: a comparative study of England and Australia [PhD dissertation] (2006), London School of Hygiene and Tropical Medicine, London
93. Ciccolallo L., Capocaccia R., Coleman M., et al. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 54 (2005) 268-273
94. Young J., Ries L., and Pollack E. Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst 73 (1984) 341-352
95. Woods L., Rachet B., and Coleman M. Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. Br J Cancer 92 (2005) 1279-1282
96. McDavid K., Tucker T., Sloggett A., and Coleman M. Cancer survival in Kentucky and health insurance coverage. Arch Intern Med 163 (2003) 2135-2144
97. Sinha A., Morgan J., Buus R., et al. Cathepsin B expression is similar in African-American and Caucasian prostate cancer patients. Anticancer Res 27 (2007) 3135-3141
98. Halpern M., Ward E., Pavluck A., Schrag N., Bian J., and Chen A. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 9 (2008) 222-231
99. Bradley C., Given C., and Roberts C. Race, socioeconomic status and breast cancer treatment and survival. J Natl Cancer Inst 94 (2002) 490-496
100. VanEenwyk J., Campo J., and Ossiander E. Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum. Cancer 95 (2002) 39-46
101. Mayberry R., Coates R., Hill H., et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 87 (1995) 1686-1693
102. Shavers V., and Brown M. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94 (2002) 334-357
103. In: Smedley B., Stith A., and Nelson A. (Eds). Unequal treatment: confronting racial and ethnic disparities in healthcare (2003), Institute of Medicine of The National Academies, Washington DC 1-764
104. Ward E., Jemal A., Cokkinides V., et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54 (2004) 78-93
105. Rabeneck L., Souchek J., and El-Serag H. Survival of colorectal cancer patients hospitalized in the Veterans Affairs health care system. Amer J Gastroenterol 98 (2003) 1186-1192
106. Brawley O. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst 94 (2002) 471-473
107. Mariotto A., Capocaccia R., Verdecchia A., Micheli A., Feuer E., and Pickle L. Projecting SEER cancer survival rates to the US: an ecological regression approach. Cancer Causes Control 13 (2002) 101-111
108. Bossard N., Velten M., Remontet L., et al. Survival of cancer patients in France: a population-based study from the Association of French Cancer Registries (FRANCIM). Eur J Cancer 43 (2007) 149-160
109. In: Grosclaude P., Bossard N., Remontet L., et al. (Eds). Survie des patients atteints de cancer en France: étude des registres du réseau FRANCIM (2007), Springer, Lyon 1-406
110. Cooper Y. Cancer. Commons Hansard. http://www.publications.parliament.uk/pa/cm200102/cmhansrd/vo010720/text /10720w66.htm#10720w66.html_sbhd1 (accessed July 3, 2008).
111. United Nations. Demographic Yearbook 1995 (1997), UN, New York 129-135
112. United Nations. Demographic Yearbook 1992 (1994), UN, New York 512
113. Berrino F., Capocaccia R., Coleman M., et al. Survival of cancer patients in Europe: the EUROCARE-3 study (CDROM) (2003), EUROCARE Working Group, Milan
114. In: Ries L., Melbert D., Krapcho M., et al. (Eds). SEER cancer statistics review, 1975-2004 (2007), National Cancer Institute, Bethesda MD
115. Canadian Cancer Society, and National Cancer Institute of Canada. Canadian cancer statistics 2007 (2007), CCS/NCIC, Toronto
116. Yu X., O'Connell D., Gibberd R., Smith D., and Armstrong B. Cancer survival, incidence and mortality by Area Health Service in NSW 1994 to 2000 (2003), The Cancer Council, New South Wales, Sydney
117. English D., Farrugia H., Thursfield V., Chang P., and Giles G. Cancer survival, Victoria, 2007: estimates of survival in 2004 and comparisons with earlier periods (2007), The Cancer Council Victoria, Melbourne
118. Ajiki W, Sobue T, Tsukuma H. Survival of cancer patients diagnosed in 1993-99: a collaborative study of population-based cancer registries in Japan. 19th Annual Meeting of the Japanese Epidemiology Association, Tokyo, Japan. Jan 26, 2008, PP086.
119. Brasso K., Friis S., Kjær S.K., Jørgensen T., and Iversen P. Prostate cancer in Denmark: a 50-year population-based study. Urology 51 (1998) 590-594
120. Borre M., and Iversen P. Screening for prostatacancer-hvad siger evidensen?. Ugeskr Læger 169 (2007) 1887-1888
121. Dansk Urologisk Selskab. Prostatacancer 2006-status og nye udfordringer. Ugeskr Læger 168 (2006) 1243
122. Ministry of Health Labour and Welfare. National survey on the life of the people, 2004. Ministry of Health, Labour and Welfare Statistical Database. http://wwwdbtk.mhlw.go.jp/toukei/index.html (accessed Feb 1, 2008).
123. Parkin D. The evolution of the population-based cancer registry. Nat Rev Cancer 6 (2006) 603-612
124. Verdecchia A., Baili P., Quaglia A., et al. Patient survival for all cancers combined as indicator of cancer control in Europe. Eur J Public Health (2008) 10.1093/eurpub/ckn022 published online April 15.
125. Micheli A., Capocaccia R., Martinez-Garcia C., et al. Cancer control in Europe: a proposed set of European Cancer Health Indicators. Eur J Public Health 13 suppl 3 (2003) 1-3
126. Gorey K., Holowaty E., Fehringer G., Laukkanen E., Richter N., and Meyer C. An international comparison of cancer survival: relatively poor areas of Toronto, Ontario and three US metropolitan areas. J Public Health Med 22 (2000) 343-348
127. Sankaranarayanan R., Black R., Swaminathan R., and Parkin D. An overview of cancer survival in developing countries. In: Sankaranarayanan R., Black R., and Parkin D. (Eds). Cancer survival in developing countries (1999), IARC, Lyon 135-155
128. Sankaranarayanan R., Swaminathan R., and Black R. Global variations in cancer survival. Cancer 78 (1996) 2461-2464
129. Woods L., Rachet B., and Coleman M. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 17 (2006) 5-19
130. Kogevinas M., and Porta M. Socioeconomic differences in cancer survival: a review of the evidence. In: Kogevinas M., Pearce N., Susser M., and Boffetta P. (Eds). Social inequalities and cancer (1997), IARC Scientific Publications No 138, Lyon 177-206